FORA Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

FORA Capital’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26,176	Closed	-$3.45M	–	749
2025 Q1	$3.45M	Buy	+26,176	New	+$3.26M	0.35%	91
2023 Q3	–	Sell	-8,332	Closed	-$528K	–	603
2023 Q2	$528K	Sell	8,332 -5,960	-42%	-$371K	0.07%	228
2023 Q1	$774K	Buy	+14,292	New	+$691K	0.08%	283
2021 Q3	–	Sell	-1,425	Closed	-$58K	–	917
2021 Q2	$58K	Buy	+1,425	New	+$52.7K	0.01%	690
2020 Q4	–	Sell	-5,453	Closed	-$140K	–	1171
2020 Q3	$140K	Sell	5,453 -2,466	-31%	-$56.3K	0.09%	233
2020 Q2	$203K	Buy	+7,919	New	+$160K	0.07%	336

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FORA Capital's ITCI Position: Q2 2025 in Review

FORA Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 26,176 shares — an estimated $3.45M sold.

FORA Capital first reported a position in ITCI in Q2 2020 and held it in 6 quarters. The position peaked at $3.45M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

FORA Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
FORA Capital sold 26,176 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $3.45M.
FORA Capital first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and held it in 6 quarters.
FORA Capital's Intra-Cellular Therapies Inc. position peaked at $3.45M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.